Introduction

The Pediatric Health Clinical Guide provides clinicians with a structured, evidence-informed framework for supporting optimal growth, development, and long-term health in infants, children, and adolescents.

This clinical guide takes a whole-person approach, recognizing that sleep, nutrition, movement, metabolic health, micronutrient status, and family environment are deeply interconnected and shape physical, cognitive, and emotional development. The emphasis of this clinical guide is on early identification of modifiable risk factors and prevention of chronic disease trajectories.

Clinicians will learn to interpret age-appropriate laboratory markers and implement targeted nutritional ingredients and lifestyle interventions to support healthy neurodevelopment, metabolic balance, immune function, and overall resilience throughout childhood and adolescence.

What Is Healthspan?

Healthspan describes the period of life spent in good health, free from the chronic diseases and disabilities of aging. It focuses on the period of good health and functionality in which individuals remain healthy, active, independent, and productive both mentally and physically. Ultimately, the goal of improving healthspan is remaining healthier for longer, ideally delaying the onset of chronic disease. (Masfiah 2025)

Why Pediatric Health Matters

Early development builds the foundation for later cognitive, behavioral, and overall health outcomes. The period from conception through age 2 is particularly sensitive for brain development, growth, and later school performance. Nutritional exposures in early life influence neural development, physical growth, and long-term function, while early adversity can dysregulate stress physiology and affect brain structure and function.

Early nurturing care, including adequate health support and nutrition, shapes lifelong developmental trajectories. By identifying modifiable risks and supporting foundational systems during childhood, clinicians can positively influence long-term resilience, learning capacity, metabolic health, and overall well-being. (Black 2017)

Purpose of the Clinical Guide

The Pediatric Health Clinical Guide was designed to:

1. Simplify decision-making using standardized, evidence-rated nutrient and lifestyle interventions.
2. Integrate laboratory and biomarker data to identify modifiable contributors to pediatric health.
3. Serve as the foundation for individualized care plans aimed at maintaining health through the lifespan.

Essential Labs

Screening Tests 

Age-appropriate laboratory screening supports early identification of nutrient deficiencies, metabolic risk, and inflammatory patterns that can influence growth, neurodevelopment, and long-term cardiometabolic health. Weight status should be considered when interpreting results, as excess adiposity significantly alters many commonly ordered markers in children, including liver enzymes, lipid panels, inflammatory markers, uric acid, and iron-related indices. Changes in these values may reflect adiposity-related physiology rather than acute disease. (Higgins 2020)

When ordering labs, clinicians should also practice thoughtful stewardship. Frequent blood draws can contribute to anemia, particularly in hospitalized or chronically ill children. Lab-related blood loss can be reduced by using small-volume tubes, combining tests when possible, avoiding unnecessary repeat testing, and utilizing point-of-care testing when appropriate. In healthy children, single draws up to approximately 3% of total blood volume per visit (about 2.4 mL/kg) have not been associated with anemia and were well tolerated in children 6 months–12 years who were not at risk. Additional caution is warranted in those with chronic illness or baseline anemia. (Peplow 2019)(François 2023)

Complete Blood Count with Differential (CBC with diff)

A CBC with diff is a practical tool in pediatric care that helps narrow the differential diagnosis and guide further evaluation when blood disorders are suspected. Routine baseline hematology screening with hemoglobin and hematocrit is recommended beginning at 12 months of age, or earlier when clinically indicated. (Pabón-Rivera 2023)

CBC parameters vary significantly by age and sex in pediatric populations and require age-specific interpretation. Young children normally have higher total white blood cell (WBC) counts than adults, with early childhood characterized by lymphocyte predominance. Over time, total WBC decreases and neutrophils become the predominant cell type. (Nah 2018)

Hemoglobin, hematocrit, and red blood cell (RBC) counts increase through late childhood and are similar in boys and girls until puberty. After puberty, males develop higher hemoglobin and RBC counts, while females trend lower, likely related to menstruation and lower iron stores. (Nah 2018)

Platelet counts are highest in early childhood and gradually decline with age. After puberty, females tend to have higher platelet counts than males. These dynamic, age- and sex-related changes highlight the importance of using pediatric-specific reference intervals when interpreting CBC results. (Nah 2018)

Comprehensive Metabolic Panel (CMP)

A CMP includes fasting plasma glucose and alanine aminotransferase (ALT), two key markers in pediatric metabolic evaluation. Fasting plasma glucose helps identify prediabetes (100–125 mg/dL) and diabetes (≥126 mg/dL). Testing is indicated in children with symptoms of hyperglycemia, including polyuria, polydipsia, polyphagia, blurred vision, unexplained weight loss, or fatigue. Type 2 diabetes is increasingly diagnosed in youth, and approximately 1 in 5 adolescents (12–18 years) have prediabetes. (Hampl 2023)

ALT is the preferred screening test for pediatric metabolic dysfunction–associated steatotic liver disease (MASLD). MASLD affects up to 34% of children with obesity, and prevalence increases with age (3.3% ages 5–9; 11.3% ages 10–14; 17.3% ages 15–17). Risk factors include obesity, age ≥10 years, male sex, dyslipidemia, and prediabetes or diabetes. Higher ALT levels correlate with more advanced liver disease, although normal ALT does not exclude MASLD. (Hampl 2023)

Ferritin

Ferritin is the primary laboratory marker used to assess iron stores. Iron deficiency, even without anemia, is associated with impaired brain development, fatigue, and poor physical performance, so relying on lower cutoffs may miss earlier iron deficiency, including iron deficiency without anemia. (Addo 2025)

The World Health Organization defines iron deficiency in young children as ferritin <12 μg/L. A 2025 multinational analysis identified a higher, physiologically based cutoff of about 22 μg/L (22.1 μg/L), corresponding to the point where hemoglobin begins to decline. Using about 22 μg/L nearly doubled detected iron deficiency prevalence in children (34.2% vs. 16.6% using the WHO cutoff). (Addo 2025)

Magnesium

Magnesium regulates neuromuscular function, cardiac excitability, blood pressure, insulin metabolism, immune activity, and inflammatory and oxidative stress pathways, in part through its role as a natural calcium antagonist. Serum magnesium represents only about 1% of total body magnesium, so subclinical or chronic deficiency may occur and be asymptomatic. (Escobedo-Monge 2022)

In a series of 78 children and adolescents with chronic diseases, 45% had hypomagnesemia and 79% were considered at elevated risk of abnormal magnesium status. Abnormal calcium/magnesium ratios were common and were linked to increased risk of other chronic conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. These findings highlight the frequency of altered magnesium status in pediatric chronic disease populations. (Escobedo-Monge 2022)

Vitamin D

Vitamin D deficiency remains common in healthy children aged 0–18 years. In a retrospective evaluation of 3,368 healthy children, deficiency (<12 ng/mL) and insufficiency (12–20 ng/mL) together affected 42.9% of participants. The frequency of deficiency increased with age, with adolescent girls representing the highest-risk group. (Karagol 2023)

Additional risk factors for deficiency included winter and spring season and residence north of the 40th parallel. Although routine universal testing in healthy children is not standard practice, the high prevalence of deficiency supports consideration of targeted screening in higher-risk groups. (Karagol 2023)

Ingredients

Targeted supplementation or use of nutraceuticals may sometimes be appropriate in children to address identified deficiencies, support specific physiologic needs, or complement lifestyle interventions. When indicated, dosing and formulation must be approached thoughtfully.

Pediatric pharmacokinetics differ significantly from adults due to age, body weight, body surface area, and organ development. Adult doses cannot be directly applied to children. Accurate weight-based dosing is essential, as errors may result in toxicity or ineffective treatment. No single dosing method is universally superior, and the approach should reflect the treatment properties and patient factors. Historically, weight-based approaches such as Clark’s Rule have been used when only adult dosing is available: (Weight in pounds ÷ 150) × Adult dose or (Weight in kilograms ÷ 68) × Adult dose. Many therapies transition to adult dosing around 40 kg. However, dosing should always be individualized based on weight, product labeling, and safety data rather than weight alone. In children with obesity, excess adiposity alters volume of distribution, and incorrect weight selection can lead to over- or underdosing. (Delgado 2023)

Formulation selection is equally important. Choose forms appropriate for developmental stage and swallowing ability, prioritize taste and palatability to support adherence, and minimize artificial colorings and unnecessary additives when possible. Common pediatric-friendly forms include chewables, liquids, and powders. In infants, avoid capsules and large volumes. Use appropriately formulated liquids, consider higher-concentration preparations to reduce total volume per dose, and be mindful of gag reflex and tolerability. (Khan 2022)

Omega-3 Fatty Acids (EPA/DHA)

Dosing: 450–1600 mg total per day for 12–52 weeks

Supporting evidence:

• Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation increase the Omega-3 Index and have been investigated for potential effects on executive function, cognition, and self-regulation in children and adolescents, particularly in those with lower baseline omega-3 status. (Roach 2021)(van der Wurff 2020)
• In the Omega Kid Pilot Study (preschoolers ~3–5 years, 12 weeks, 1.6 g/day EPA + DHA), supplementation resulted in a significant three-fold increase in the HS-Omega-3 Index® (p < 0.001). Higher baseline Omega-3 Index was modestly associated with better behavioral and cognitive self-regulation (r = 0.287 and r = 0.242, respectively). However, no significant improvements in executive function or self-regulation were observed compared to placebo in typically developing children. (Roach 2021)
• A systematic review of 33 randomized controlled trials (ages 4–25 years) found cognitive benefits were more likely when daily intake was ≥450 mg DHA + EPA and when Omega-3 Index increased to >6%. Approximately half of the studies in typically developing children meeting the ≥450 mg/day threshold demonstrated improved cognition. (van der Wurff 2020)
• Dietary Reference Intakes (DRIs) exist only for alpha-linolenic acid (ALA), an essential omega-3 fatty acid. Specific intake recommendations for EPA and DHA have not been established, and because conversion from ALA to these long-chain omega-3s is limited, EPA and DHA are typically obtained directly from seafood or supplements. (National Institute of Health Office of Dietary Supplements 2024)

Note: Dose may vary depending on the clinical indication. In pediatric care, higher omega-3 doses may sometimes be used for specific conditions.

Multivitamin, Multimineral (MVMM)

Dosing: Dosing may vary and should be tailored to the child’s nutritional needs and goals

Supporting evidence:

• MVMMs are the most commonly used dietary supplements in children and adolescents. In National Health and Nutrition Examination Survey (NHANES) 2017–2018, 34% of children reported using a dietary supplement in the past 30 days, with MVMM products being the most common (23.8%). (Stierman 2020)
• Nutrient density of foods has declined over time, with documented reductions in vitamin and mineral concentrations in fruits and vegetables since the mid-20th century. (Mayer 2022)
• Produce intake is low among adolescents, with only 7.1% meeting fruit intake recommendations and 2% meeting vegetable intake targets, which may contribute to micronutrient gaps. These dietary patterns may increase the likelihood of suboptimal micronutrient intake. (Lange 2021)
• Micronutrient needs and potential dietary gaps vary across developmental stages, making individualized assessment important when considering MVMM use in pediatric populations. (Bailey 2012)

Vitamin D

Dosing: 400–2000 IU per day or target 25-hydroxyvitamin D (25(OH)D) >30 ng/mL (>75 nmol/L)

Supporting evidence:

• Universal vitamin D supplementation is strongly recommended starting shortly after  birth and continuing through 12 months of age, regardless of feeding method. A daily dose of 400 IU has been shown to improve bone health and prevent rickets in infants. Supplementation is well tolerated and not associated with toxicity. (Jullien 2021)
• Lower daily doses (<400 IU) may not achieve adequate vitamin D levels. In a systematic review and network meta-analysis of 29 trials in term and late preterm neonates, regimens ≥400 IU/day increased mean 25(OH)D levels compared with no treatment, while ≤250 IU/day did not. Vitamin D supplementation of 400–600 IU/day was identified as the most effective and safest range in infants. (Abiramalatha 2024)
• In older children and adolescents, supplementation has been studied at doses up to 2000 IU/day  to support bone health and overall metabolic needs. (Demay 2024)

Probiotics 

Dosing: Typical studied pediatric doses range widely depending on strain and indication

Supporting evidence:

• Several probiotic strains have been studied in children, including Lactobacillus rhamnosus GG (ATCC 53103), Saccharomyces boulardii (CNCM I-745), and Lactobacillus reuteri (DSM 17938). (Depoorter 2021) 
• Evidence supports strain- and condition-specific benefits, with the strongest data for treatment of infectious gastroenteritis and prevention of antibiotic-associated diarrhea, Clostridioides difficile–associated diarrhea, and nosocomial diarrhea. (Depoorter 2021)
• Probiotics are generally well tolerated in healthy pediatric populations with a low risk of adverse events. Rare systemic infections have been reported, primarily in medically complex or immunocompromised children. (Depoorter 2021)

Magnesium

Dosing: 65–350 mg per day (elemental magnesium, depending on age)

Forms used in studies include oxide, hydroxide, citrate, lactate, sulfate, and others

Supporting evidence:

• In healthy girls ages 8–14 years with dietary magnesium intake <220 mg/day, supplementation with 300 mg elemental magnesium daily for 12 months was found to significantly increase hip bone mineral content accrual compared with placebo. Magnesium oxide was safe and well tolerated. (Carpenter 2006)
• In a small study of children and adolescents ages 7–19 years with moderate persistent asthma, 300 mg/day oral magnesium for two months was associated with reduced bronchial reactivity, decreased exacerbations, and reduced rescue medication use compared with placebo. (Gontijo-Amaral 2006)
• In another small study of children with attention-deficit/hyperactivity disorder (ADHD), magnesium (6 mg/kg/day) combined with vitamin D for eight weeks was associated with significantly improved emotional, conduct, peer, and total behavioral difficulty scores compared with placebo. (Hemamy 2021)
• In a small randomized controlled trial of children older than six months with functional constipation, magnesium oxide was associated with significantly improved stool frequency and reduced stool consistency in a randomized controlled trial. (Kubota 2020)
• In children aged 3–17 years, magnesium (~9 mg/kg/day) has been studied for migraine prevention and is associated with reduced headache frequency and severity, though evidence remains limited. (Wang 2003)
• Oral supplementation may cause gastrointestinal symptoms at higher doses and should be used with caution in renal insufficiency. (Guerrera 2009)

Lifestyle Recommendations

Nutrition

Risk Factors

Dietary patterns established in infancy and early childhood are associated with measurable health outcomes later in life. Higher or increasing sugar intake in early life is associated with increased risk of dental caries, and persistently poor diet quality or high intake of energy-dense, nutrient-poor foods is associated with greater adiposity and adverse cardiometabolic markers in adolescence and adulthood. These findings suggest that early excess exposure to added sugars and low nutrient-density foods may contribute to long-term metabolic risk. (Zheng 2025)

Interventions

Adherence to nutrient-dense dietary patterns beginning in infancy and continuing through childhood supports healthy growth and long-term health foundations. Clinical recommendations include: (American Family Physician 2021)

• At least one-half of food eaten should be fruits and vegetables, especially whole fruits and vegetables of a variety of colors (for children two years and older).
• Include grains (with at least one-half whole grains), dairy, and protein sources as the remaining core components of intake.
• Choose nutrient-dense foods and beverages that are lower in added sugars, saturated fat, and sodium.
• Avoid sugar-sweetened beverages, and prioritize water and unsweetened milk.
• During the first four months of life, breast milk is the optimal sole source of nutrition when available.
• Introduce nutrient-dense complementary foods between 4–6 months, prepared to reduce choking risk.
• Introduce potentially allergenic foods such as peanuts, tree nuts, egg, soy, and shellfish around six months of age alongside other complementary foods.
• Limit foods high in added sugars and sodium in infancy and childhood.

Movement

Risk Factors

Modern youth spend a substantial portion of waking hours sedentary, with school-aged children averaging approximately eight hours per day of sedentary time and most exceeding recommended screen limits. Recreational screen time is consistently associated with adiposity in children and adolescents, and screen exposure increases substantially with age, particularly during preadolescence and adolescence. Excess sedentary behavior may also displace outdoor play, social interaction, sleep, and physical activity, contributing to unfavorable cardiometabolic patterns over time. (Barnett 2018)

Interventions

Movement should be individualized to developmental stage, interests, and health status, incorporating both higher-intensity activity and restorative forms such as walking, yoga, tai chi, or stretching. Encouraging enjoyable, child-selected movement fosters intrinsic motivation while supporting physical health, stress regulation, and overall well-being. (Liu 2021)(Jarraya 2019)(Carlin 2016)

Stress

Risk Factors

Exposure to adverse childhood experiences is associated with increased risk of chronic disease, depression, post-traumatic stress symptoms, and health risk behaviors in adulthood. (Chang 2019) Beyond early adversity, persistent psychosocial stress during childhood and adolescence—including academic, peer, family, and relational stress—is associated with significantly higher odds of depression, anxiety, and emotional and behavioral problems. High or sustained stress trajectories appear particularly impactful, suggesting that cumulative stress exposure during development has been associated with differences in emotional regulation and long-term health outcomes. (Zhang 2026)

Interventions

Stress resilience can be strengthened through structured self regulation and mindfulness-based practices. School-based mindfulness interventions demonstrate high-quality evidence for improving resilience, executive function, attention, and prosocial behavior while reducing anxiety, conduct problems, and attention related symptoms. (Phan 2022) Universal self-regulation programs across early childhood and adolescence show moderate effect sizes for improving self-regulation skills and are associated with improved academic performance, behavioral outcomes, and reduced risk behaviors. (Pandey 2018) Supporting emotional regulation skills early may buffer stress exposure and promote long-term mental and physical well being.

Sleep

Risk Factors

Insomnia is common in childhood, affecting 20–30% of infants and toddlers and up to one-third of adolescents. It includes difficulty initiating sleep, maintaining sleep, early-morning awakening, or non-restorative sleep and is associated with significant stress for children and parents and impaired daytime functioning. Pediatric insomnia is associated with learning difficulties, behavioral problems, reduced quality of life, obesity, and suicidality. (Schlarb 2025)

Nightmares are a common comorbidity. About 15–24% of children and adolescents with insomnia also have comorbid nightmares, and adolescents with both insomnia and nightmares report greater anxiety and depressive symptoms. (Schlarb 2025) Behavioral insomnia patterns often contribute, including sleep-onset association type and limit-setting type, and many children present with a mixed pattern. (Deshpande 2022)

Interventions

First-line treatment is behavioral intervention with parent education and consistent routines. Keep bedtime and wake time consistent daily. Build a calming bedtime routine (bath, reading) and encourage independent sleep by placing the child down awake to promote self-soothing. Use extinction techniques appropriately for bedtime resistance or night awakenings. (Deshpande 2022)

Optimize the sleep environment by keeping the bedroom dark, quiet, and comfortably cool, and minimizing external noise. Limit electronics before bed and avoid vigorous activity close to bedtime. Regular daytime physical activity supports sleep quality, with caution about exercise too close to bedtime. If needed, a small snack is reasonable, while avoiding large meals, excessive fluids, and caffeine before bedtime. (Deshpande 2022)

Because comorbid nightmares are common and linked with greater emotional burden in adolescents, insomnia evaluations should screen for nightmares and related anxiety or depressive symptoms. (Schlarb 2025) Hypnotic medications are not recommended as first-line therapy and require specialist oversight if considered. (Deshpande 2022)

Environment 

Risk Factors

Environmental toxicants meaningfully influence pediatric development. Lead exposure, even at blood lead levels below 10 µg/dL, is associated with impaired cognitive, motor, behavioral, and physical development, and no clear safe threshold has been identified. (Binns 2007) Ambient air pollution, including particulate matter (PM2.5), nitrogen dioxide (NO₂), ozone, and polycyclic aromatic hydrocarbons, has been linked with adverse birth outcomes, reduced lung development, increased asthma incidence, neurodevelopmental impacts, and long-term cardiometabolic risk in children. (Brumberg 2021)(Castagna 2022) Prenatal and early-life exposures appear to be particularly sensitive periods, with oxidative stress, inflammation, endocrine disruption, and epigenetic mechanisms contributing to downstream effects, and children are uniquely vulnerable because of higher air intake per body weight and developing organ systems. (Brumberg 2021)

Interventions

Environmental risk reduction is a foundational pediatric strategy. Clinicians should obtain an environmental exposure history, follow local blood lead screening guidance, and counsel families on creating lead-safe home environments, including attention to older housing, water sources, and renovation exposures. (Binns 2007) Families should be educated about the Air Quality Index and encouraged to limit outdoor exertion during poor air quality days, avoid proximity to heavy traffic when possible, and reduce indoor pollutant sources such as smoking or combustion exposures. Broader strategies including safe housing policies, reduced industrial and traffic emissions, and community-level clean air initiatives have demonstrated measurable health benefits in children. (Brumberg 2021) Early-life environmental optimization supports neurodevelopment, respiratory health, and long-term physiologic resilience. (Brumberg 2021)(Castagna 2022)